Immunophenotyping of matched pre- and post-ICI samples demonstrated significant decreases in intratumoral lymphocytes, CD3e+ and CD8a+ T cells, and PD-L1/PD-1 engagement, as well as increased distance between tumor cells and CD8+ PD-1+ T cells. The gene discussed is CD8A; the disease is neoplasm.